PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
28-Jan-2025 Oncopeptides’ Pepaxti formally approved for full reimbursement in Italy Oncopeptides
28-Jan-2025 Cancer Research Horizons partners with Lifebit to maximise the impact of research data Cancer Research Horizons
28-Jan-2025 Clinigen Announces Strategic Partnership with Tepsivo Clinigen
28-Jan-2025 GSK’s Shingrix new prefilled syringe presentation accepted for review by European Medicines Agency GSK
28-Jan-2025 Legal & General completes £1.4 billion buy-in with the Sanofi Pension Scheme Legal & General
28-Jan-2025 ENA Respiratory Publishes Review of Development of Novel Intranasal Antiviral Host Defense Immune Enhancer INNA-051 in Antiviral Research ENA Respiratory
28-Jan-2025 Cosmos Health Secures Bond Loan from European Bank on Very Competitive Terms, with Option to Upsize to Support Growth and Achieve Positive Operating Cash Flow AccessWire
28-Jan-2025 Glidewell to Host Nine Symposia in 2025 AccessWire
28-Jan-2025 Novadip reports 12-month results from phase 1b/2a trial of NVD003 to treat rare pediatric disease Congenital Pseudarthrosis of the Tibia Andrew Lloyd Associates
28-Jan-2025 Unlocking Protein Potential: EvoSelect® and Directed Evolution Isomerase
28-Jan-2025 Isomerase and BugBiome Partner to Advance Sustainable Crop Protection via Targeted Novel Bioinsecticides Isomerase
28-Jan-2025 Isomerase Launches Isochassis - Microbial Hosts for Scalable Protein Production Isomerase
28-Jan-2025 Commit Biologics announces €5.5m seed financing extension investment by Korys to further develop its Bispecific Complement Engaging (BiCE™) platform Commit Biologics
28-Jan-2025 Next Generation Cancer Diagnostics Market Will Reach USD 42.0 Billion by 2034 Prophecy Market Insights
28-Jan-2025 Vect-Horus further strengthens leadership with appointment of strategy and finance executive Jérôme Berger to its Board of Directors Vect-Horus
28-Jan-2025 OncoZenge enters into SEK 30.2 million investment agreement with new strategic investor Sichuan Yangtian Bio-Pharmaceutical, intended to be carried out through directed share issues OncoZenge
28-Jan-2025 Burnout crisis: Why UK doctors are missing out on AI lifelines Corti / YouGov
28-Jan-2025 AGFA HealthCare at HIMSS 2025: Revolutionizing Enterprise Imaging with Innovation and Work-Life Balance AccessWire
28-Jan-2025 FDA Grants Priority Review to Merck’s Application for WELIREG® (belzutifan) for the Treatment of Patients With Advanced Pheochromocytoma and Paraganglioma (PPGL) Merck
28-Jan-2025 Roche’s Itovebi demonstrated statistically significant and clinically meaningful overall survival benefit in a certain type of HR-positive advanced breast cancer Roche